Biblio Discovery — Demo Discovery Service

8 hasil untuk "Li-Ping Dou"

Menampilkan 1–8 · 0,67 detik · RSS

  1. Artikel Jurnal

    Efficacy and Safety of Unmanipulated Haploidentical Related Donor Allogeneic Peripheral Blood Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia

    Li-Ping Dou; Hong-Hua Li; Lu Wang dkk.

    Chinese Medical Journal, Vol. 131 No. 7 · 2018 · Inggris · DOAJ Scopus

    Background: Studies of haploidentical-related donor (HRD) stem cell transplantation using a combination of peripheral blood stem cells (PBSCs) and bone marrow as the graft have reported encouraging results for patients with hematological diseases. However, few studies specifically reported…

  2. Artikel Jurnal

    Investigation of Invigorating Qi and Activating Blood Circulation Prescriptions in Treating Qi Deficiency and Blood Stasis Syndrome of Ischemic Stroke Patients: Study Protocol for a Randomized Controlled Trial

    Yu Wang; Ling Zhang; Yuan-jiang Pan dkk.

    Frontiers in Pharmacology, Vol. 11 · 2020 · Inggris · DOAJ Scopus

    Ischemic stroke (IS) is characterized by high morbidity and high mortality. The integration of Traditional Chinese medicine (TCM) and western medicine has shown promising benefits in relieving symptoms, promoting neurological recovery, and improving the quality of life of patients with IS. In TCM…

  3. Artikel Jurnal

    Preemptive interferon-α therapy could prevent relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: A real-world analysis

    Shuang Fan; Tian-Zhong Pan; Li-Ping Dou dkk.

    Frontiers in Immunology, Vol. 14 · 2023 · Inggris · DOAJ Scopus

    IntroductionMeasurable residual disease (MRD)-directed interferon-a treatment (i.e. preemptive IFN-α treatment) can eliminate the MRD in patients with acute myeloid leukemia (AML) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Therefore, this study aimed to further assess its…

  4. Artikel Jurnal

    Increased risk of cardio-cerebrovascular disease after hematopoietic cell transplantation in patients with previous history

    Bo Peng; Li-Li Wang; Li-Ping Dou dkk.

    Chinese Medical Journal, Vol. 134 No. 12 · 2021 · Inggris · DOAJ Scopus

    Abstract. Background:. The impacts of previous cardio-cerebrovascular disease (pre-CCVD) on the outcomes of hematopoietic cell transplantation (HCT) are not well described. Patients with pre-CCVD may often be poor candidates for HCT. This study aimed to investigate the impact of pre-CCVD on…

  5. Artikel Jurnal

    Chidamide increases the sensitivity of refractory or relapsed acute myeloid leukemia cells to anthracyclines via regulation of the HDAC3 -AKT-P21-CDK2 signaling pathway

    Hao Wang; Yu-chen Liu; Cheng-ying Zhu dkk.

    Journal of Experimental & Clinical Cancer Research, Vol. 39 No. 1 · 2020 · Inggris · DOAJ Scopus

    Abstract Background Induction therapy for acute myeloid leukemia (AML) is an anthracycline-based chemotherapy regimen. However, many patients experience a relapse or exhibit refractory disease (R/R). There is an urgent need for more effective regimens to reverse anthracycline resistance in these…

  6. Artikel Jurnal

    Low-dose baricitinib plus danazol in primary immune thrombocytopenia: a randomized, controlled phase 2 trial

    Peng Zhao; Zhuo-Yu An; Hai-Xia Fu dkk.

    Nature Communications, Vol. 17 No. 1 · 2026 · Inggris · DOAJ Scopus

    Abstract This multicenter, randomized, controlled study was conducted to explore the safety and efficacy of low-dose baricitinib plus danazol for ITP patients who had failed corticosteroids and at least one recommended subsequent treatment. Participants were randomly assigned to receive baricitinib…

  7. Artikel Jurnal

    Detection of an anti-angina therapeutic module in the effective population treated by a multi-target drug Danhong injection: a randomized trial

    Jun Liu; Dan-Dan Li; Wei Dong dkk.

    Signal Transduction and Targeted Therapy, Vol. 6 No. 1 · 2021 · Inggris · DOAJ Scopus

    Abstract It’s a challenge for detecting the therapeutic targets of a polypharmacological drug from variations in the responsed networks in the differentiated populations with complex diseases, as stable coronary heart disease. Here, in an adaptive, 31-center, randomized, double-blind trial…